Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : Snynf    crawled date : 2022 - 12 - 08    save search

Alnylam Submits Supplemental New Drug Application (sNDA) to U.S. Food and Drug Administration (FDA) for ONPATTRO® (patisiran) for the Treatment of the Cardiomyopathy of ATTR Amyloidosis
Published: 2022-12-08 (Crawled : 22:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 twitter stocktwits trandingview |
Health Technology
| | O: 0.5% H: 0.16% C: 0.16%
SNY | News | $46.66 -2.16% -2.21% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -1.32% H: 0.0% C: 0.0%
ALNY | $143.8 -1.55% -1.58% 390K twitter stocktwits trandingview |
Health Technology
| | O: 0.43% H: 3.16% C: 2.44%

onpattro treatment drug application food
COALITION TO STOP FLU APPLAUDS INTRODUCTION OF LEGISLATION TO BETTER PROTECT AMERICA FROM SEASONAL AND PANDEMIC INFLUENZA
Published: 2022-12-08 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480 twitter stocktwits trandingview |
Health Technology
| | O: -0.89% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.15% H: 0.0% C: 0.0%

america influenza
Sanofi Backs Out of Revolution Partnership in Latest Cancer Cull
Published: 2022-12-08 (Crawled : 16:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 twitter stocktwits trandingview |
Health Technology
| | O: 0.5% H: 0.16% C: 0.16%
SNY | News | $46.66 -2.16% -2.21% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -1.32% H: 0.0% C: 0.0%
RVMD | $35.56 -1.93% -1.97% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 1.41% H: 1.22% C: 1.06%

partnership cancer sanofi
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years
Published: 2022-12-08 (Crawled : 16:00) - globenewswire.com
FNCTF | News | $11.16 -20.84% 130 twitter stocktwits trandingview |
Communications
| | O: -0.76% H: 0.0% C: 0.0%
SNYNF | News | $94.25 -2.18% 480 twitter stocktwits trandingview |
Health Technology
| | O: 0.5% H: 0.16% C: 0.16%
PFE | News 4 | $26.27 -0.19% -0.15% 23M twitter stocktwits trandingview |
Health Technology
| | O: -0.12% H: 3.36% C: 3.19%
SNY | News | $46.66 -2.16% -2.21% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -1.32% H: 0.0% C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K twitter stocktwits trandingview |
Health Technology
| | O: 0.37% H: 5.31% C: 5.26%

covid-19 fda children vaccine authorization
Wren Taps Vertex Veteran Executives and Other Leaders to Advance First-in-Class Small-Molecule Drugs into Clinical Testing for Neurodegenerative Diseases
Published: 2022-12-08 (Crawled : 15:20) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 twitter stocktwits trandingview |
Health Technology
| | O: 0.5% H: 0.16% C: 0.16%
SNY | News | $46.66 -2.16% -2.21% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -1.32% H: 0.0% C: 0.0%

neurodegenerative
LISCure's Phase 2 Drug Candidate Granted Orphan Drug Designation (ODD) from US FDA
Published: 2022-12-08 (Crawled : 14:20) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480 twitter stocktwits trandingview |
Health Technology
| | O: 0.5% H: 0.16% C: 0.16%
SNY | News | $46.66 -2.16% -2.21% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -1.32% H: 0.0% C: 0.0%

fda designation drug candidate granted phase 2
CANCER RESEARCH INSTITUTE VIRTUAL IMMUNOTHERAPY PATIENT SUMMIT IS NOW AVAILABLE FREE, ON-DEMAND
Published: 2022-12-08 (Crawled : 12:20) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480 twitter stocktwits trandingview |
Health Technology
| | O: 0.5% H: 0.16% C: 0.16%
LLY | News | $732.2 -1.81% 0.18% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.35% H: 0.0% C: -0.39%
SNY | News | $46.66 -2.16% -2.21% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -1.32% H: 0.0% C: 0.0%
REGN | News | $906.55 -0.09% -0.08% 370K twitter stocktwits trandingview |
Health Technology
| | O: -0.81% H: 2.76% C: 0.97%

research immunotherapy cancer
Lung cancer therapeutics market size to grow by USD 10,204.33 million: High prevalence of lung cancer remains key growth driver - Technavio
Published: 2022-12-08 (Crawled : 08:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K twitter stocktwits trandingview |
Health Technology
| | O: 1.92% H: 0.0% C: 0.0%
SNYNF | News | $94.25 -2.18% 480 twitter stocktwits trandingview |
Health Technology
| | O: 0.5% H: 0.16% C: 0.16%
AZNCF | News | $140.3 -4.19% 1.5K twitter stocktwits trandingview |
Health Technology
| | O: 2.24% H: 0.0% C: 0.0%
NVSEF | News | $96.0 6.88% 52K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: 0.0%
ALPMY | News | $9.49 -1.11% 480K twitter stocktwits trandingview |
Manufacturing
| | O: 1.24% H: 0.97% C: 0.19%
NVS | News | $98.35 1.1% 0.0% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: -1.17% H: 1.09% C: 1.01%
GSK | News | $40.86 -0.92% -0.15% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -1.41% H: 1.75% C: 0.66%
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.5% C: 0.36%
SNY | News | $46.66 -2.16% -2.21% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -1.32% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.13% H: 0.76% C: 0.33%
AMGN | News | $273.085 -0.17% -0.17% 2.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.26% H: 0.03% C: -0.33%

lung therapeutics cancer growth market
Endocrinology drugs market size to grow by USD 36551.24 Million: Increase in the incidence of endocrine disorders remains key growth driver - Technavio
Published: 2022-12-07 (Crawled : 00:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K twitter stocktwits trandingview |
n/a
| | O: 0.0% H: 11.11% C: 2.78%
GLAXF | News | $19.54 -14.18% 2.6K twitter stocktwits trandingview |
Health Technology
| | O: 1.92% H: 0.0% C: 0.0%
SNYNF | News | $94.25 -2.18% 480 twitter stocktwits trandingview |
Health Technology
| | O: 0.5% H: 0.16% C: 0.16%
NVSEF | News | $96.0 6.88% 52K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: -1.17% H: 1.09% C: 1.01%
GSK | News | $40.86 -0.92% -0.15% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -1.41% H: 1.75% C: 0.66%
ABT | News | $106.89 -0.65% -0.22% 5.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.14% H: 2.32% C: 2.16%
SNY | News | $46.66 -2.16% -2.21% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -1.32% H: 0.0% C: 0.0%
ORMP A | $2.375 1.06% 1.05% 41K twitter stocktwits trandingview |
Health Technology
| | O: 0.48% H: 4.55% C: 3.47%

endocrine growth market endocrine disorders
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.